RP Bio Inc. (KOSDAQ:314140)
South Korea
· Delayed Price · Currency is KRW 6,180.00
-30.00 (-0.48%)
At close: Apr 28, 2026
RP Bio Market Cap
RP Bio has a market cap or net worth of 54.16 billion as of April 29, 2026. Its market cap has increased by 21.60% in one year.
Market Cap
54.16B
Enterprise Value
58.99B
Revenue
136.22B
Ranking
n/a
PE Ratio
11.55
Stock Price
6,180.00
Market Cap Chart
Since September 29, 2022, RP Bio's market cap has decreased from 143.18B to 54.16B, a decrease of -62.17%. That is a compound annual growth rate of -23.76%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 29, 2026 | 54.16B | -15.54% |
| Dec 30, 2025 | 64.13B | 46.53% |
| Dec 30, 2024 | 43.77B | -41.62% |
| Dec 28, 2023 | 74.96B | -26.88% |
| Dec 29, 2022 | 102.52B | -28.40% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Korea Arlico Pharm | 56.10B |
| Eagle Veterinary Technology Co.,Ltd | 50.88B |
| Kyung Nam Pharm | 60.10B |
| HLscience | 46.75B |
| Jin Yang Pharmaceutical | 63.00B |
| Korean Drug | 46.16B |
| BL Pharmtech | 67.54B |
| GeneBioTech Co. ,Ltd | 41.16B |